• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4591707)   Today's Articles (1498)   Subscriber (49313)
Number Citation Analysis
1
A phase 1, open-label, dose escalation, safety, PK and PD study of a first in class Pol1 inhibitor (CX-5461) in patients with advanced hematologic malignancies (HM). J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e22212] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
2
Association of interleukin-10 promoter region polymorphisms with risk factors of Atherosclerosis. Int J Immunogenet 2014;42:31-7. [PMID: 25421362 DOI: 10.1111/iji.12156] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2014] [Revised: 09/24/2014] [Accepted: 10/06/2014] [Indexed: 11/27/2022]
3
[Postoperative nursing of patients with benign prostatic hyperplasia following treatment with net-stents]. ZHONGHUA HU LI ZA ZHI = CHINESE JOURNAL OF NURSING 1996;31:642-4. [PMID: 9304921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA